Although many mechanisms might participate in the cardioprotective effect of fenofibrate such as its anti-inflammatory effect, our results demonstrate that activation of the Ang II/AT1 pathway leads to oxidative stress and the presence of myocardial insulin resistance in MetS rats. Here, AGT is linked to metabolic syndrome.